These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15270848)

  • 1. Prevention of experimental autoimmune encephalomyelitis in DA rats by grafting primary skin fibroblasts engineered to express transforming growth factor-beta1.
    Zargarova T; Kulakova O; Prassolov V; Zharmukhamedova T; Tsyganova V; Turobov V; Ivanov D; Parfenov M; Sudomoina M; Chernajovsky Y; Favorova O
    Clin Exp Immunol; 2004 Aug; 137(2):313-9. PubMed ID: 15270848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors.
    Piccirillo CA; Prud'homme GJ
    Hum Gene Ther; 1999 Aug; 10(12):1915-22. PubMed ID: 10466625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.
    Chen LZ; Hochwald GM; Huang C; Dakin G; Tao H; Cheng C; Simmons WJ; Dranoff G; Thorbecke GJ
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12516-21. PubMed ID: 9770517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
    Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
    J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production.
    Harbige LS; Layward L; Morris-Downes MM; Dumonde DC; Amor S
    Clin Exp Immunol; 2000 Dec; 122(3):445-52. PubMed ID: 11122253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal administration of transforming growth factor-beta1 induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis.
    Ishikawa M; Jin Y; Guo H; Link H; Xiao BG
    Mult Scler; 1999 Jun; 5(3):184-91. PubMed ID: 10408719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK.
    Khalil N; Xu YD; O'Connor R; Duronio V
    J Biol Chem; 2005 Dec; 280(52):43000-9. PubMed ID: 16246848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically modified dermal keratinocytes express high levels of transforming growth factor-beta1.
    Ghahary A; Tredget EE; Chang LJ; Scott PG; Shen Q
    J Invest Dermatol; 1998 May; 110(5):800-5. PubMed ID: 9579549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent.
    Ghahary A; Tredget EE; Ghahary A; Bahar MA; Telasky C
    Wound Repair Regen; 2002; 10(5):328-35. PubMed ID: 12406170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.
    Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z
    Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
    Racke MK; Dhib-Jalbut S; Cannella B; Albert PS; Raine CS; McFarlin DE
    J Immunol; 1991 May; 146(9):3012-7. PubMed ID: 1707929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexicity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats.
    Xu LY; Ishikawa M; Huang YM; Levi M; van der Meide PH; Wahren B; Link H; Xiao BG
    Clin Immunol; 2000 Apr; 95(1 Pt 1):70-8. PubMed ID: 10794434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 inhibits protracted-relapsing experimental autoimmune encephalomyelitis by activating dendritic cells.
    Jin YX; Xu LY; Guo H; Ishikawa M; Link H; Xiao BG
    J Autoimmun; 2000 May; 14(3):213-20. PubMed ID: 10756083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
    Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
    Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.